Navigation Links
Angiotech elects to suspend Vascular Wrap(TM) pivotal clinical trials
Date:4/21/2008

VANCOUVER, April 21 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, today announced that it has elected to suspend enrolment in its U.S. and EU human clinical trials for its Vascular Wrap product candidate in patients undergoing surgery for hemodialysis access, pending a safety review to evaluate an imbalance of infections that have been observed between the two study groups. The U.S. and EU trials each consist of two study groups; (1) patients who received the graft/Vascular Wrap combination; and, (2) patients who received the graft alone.

At the onset of this study Angiotech established an independent Data Safety Monitoring Board (DSMB) in the U.S. to monitor any unexpected risks or safety issues. Angiotech recently submitted a safety summary of adverse events from the U.S. clinical trial to the DSMB, based upon having reached the 25% enrolment threshold in the U.S. clinical trial. Subsequent to that submission, Angiotech received a communication from the DSMB that one of the study groups had a greater incidence of implant site infection in comparison with the other study group. Angiotech is blinded to the groups and not currently aware of whether the increased rate of infection is in the patient group that received the graft/Vascular Wrap combination or in the patient group that received the graft alone. As a result of these observations, Angiotech has elected to notify physicians to suspend further enrolment in the trials, pending a full review of the potential cause of the implant site infections.

"We regard patient safety as the paramount obligation of any company in our industry, and upon further adjudication of the clinic
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Angiotechs Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System
2. Angiotechs novel 5-FU Central Venous Catheter receives FDA 510(k) clearance
3. Angiotech announces director resignation
4. Angiotech announces commercial launch of Cook Medicals Zilver(R) PTX(TM) drug-eluting peripheral stent in New Zealand
5. Angiotech to participate in Credit Suisse Global Leveraged Finance Conference
6. 960-Patient Study Demonstrates Zero Blood Stream Infection In Patients Treated With Angiotechs Novel 5-FU Central Venous Catheter
7. Angiotech to participate in Lehman Brothers Healthcare Conference
8. Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006
9. Angiotech and Rex Medical announce exclusive licensing and distribution agreement for the "Option(TM)" inferior vena cava filter
10. Angiotech showcases its Hemostream(TM) Dialysis Catheter at the Society of Interventional Radiology (SIR) Annual Meeting
11. Angiotech announces results for the fourth quarter ended December 31, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... available in German . ... quantum dots in a semiconductor layer. Quantum dots are small ... processes. If a short laser pulse is fired at the ... dot experiences a change in the electromagnetic field around it. ... of light by the dot. As soon as the refractive ...
(Date:9/30/2014)... is available in German . ... Universitt Mnchen (TUM) have demonstrated a new kind of ... that future computer chips could be based on three-dimensional ... main enabling technology of the semiconductor industry CMOS ... TUM researchers and collaborators at the University of Notre ...
(Date:9/30/2014)... NEW YORK , Sept. 30, 2014 /PRNewswire/ ... Review - 2014 Summary Global Markets ... Review - 2014, provides an overview of the ... focus. This report provides comprehensive information on ... Biotechnology, LLC,s, complete with comparative analysis at various ...
(Date:9/30/2014)... Shimadzu Scientific Instruments has released the ... precise tool for measuring displacement in rubber and ... maximum movement distance, the DSES-1000 can measure elongations ... of 10 mm. In addition, it achieves +/- ... and within +/- 100 µm below 50-mm stroke. ...
Breaking Biology Technology:Ultrafast remote switching of light emission 2A new dimension for integrated circuits: 3-D nanomagnetic logic 2A new dimension for integrated circuits: 3-D nanomagnetic logic 3Pacific Northwest Biotechnology, LLC - Product Pipeline Review - 2014 2Pacific Northwest Biotechnology, LLC - Product Pipeline Review - 2014 3Shimadzu’s New Long-Travel Extensometer Increases Precision for Soft Material Testing 2
... 27, 2011 Life Technologies Corporation (NASDAQ: ... presentation to investors as part of the Morgan Stanley ... which is being held at the company,s headquarters in ...  David Hoffmeister, Life Technologies, Senior Vice President and Chief ...
... Thirty years after the first American baby from in ... replaced the limits of medical know-how as the chief reason ... Arizona,s largest fertility clinic. "Compared to the early ... greater," says Dr. Drew Moffitt, of Arizona Reproductive Medicine ...
... Fla., April 27, 2011 Dyadic International, Inc. ("Dyadic") ... the discovery, development, manufacture and sale of enzyme and ... industries, announced today that it has been issued U.S. ... by the United States Patent and Trademark Office ...
Cached Biology Technology:Life Technologies to Webcast Investor Presentation as Part of the Morgan Stanley West Coast Medtech and Life Science Tools Bus Trip 2Thirty Years After 1st American "Test-Tube Baby," Economy May Be Biggest Obstacle for Infertile Couples 2New U.S. Patent Issued to Dyadic International 2New U.S. Patent Issued to Dyadic International 3
(Date:9/30/2014)... , Sept. 30, 2014  Spectra ... solutions for the biotech and power generation ... new RECONN Bioprocess Manager, an easy-to-use and ... geared towards bioprocess development laboratories. ... disparate bioreactor and analyzer systems. Accessing and ...
(Date:9/29/2014)... new study confirms that the exposure to tar tended ... of regular cigarettes. Similarly, exposure to nicotine tended ... popular type of cigarette in several countries around the ... certain toxic chemicals in the smoke of these cigarettes ... lower levels of chemicals in the smoke are not ...
(Date:9/29/2014)... CORVALLIS, Ore. Parents with children at home should ... from Oregon State University are recommending, after a new ... and asthma, asthma symptoms and chronic bronchitis. , "In ... the prevalence of asthma and wheezing is higher than ... ventilation," said Ellen Smit, an associate professor in the ...
Breaking Biology News(10 mins):Spectra Automation Introduces RECONN Bioprocess Manager 2Slim cigarette smokers not exposed to more harmful chemicals 2Childhood asthma linked to lack of ventilation for gas stoves, OSU study shows 2Childhood asthma linked to lack of ventilation for gas stoves, OSU study shows 3
... University of Texas Medical Branch at Galveston have identified women ... acetate, more commonly known as Depo-Provera or the birth control ... use DMPA will gain weight and will help physicians to ... 5 percent within the first six months of use, called ...
... research shows that training your brain may be just as ... injuries, and suggests a shift from performance-based to prevention-based athletic ... is one of the four major ligaments of the knee, ... well as an economic strain on the medical system. ...
... 2009 Scientists at Burnham Institute for Medical Research (Burnham) ... a major role in promoting programmed cell death (apoptosis), helps ... and invade surrounding tissues. The study was published in the ... team of scientists, led by Kristiina Vuori, M.D., Ph.D., professor ...
Cached Biology News:UTMB study identifies women at risk of gaining excessive weight with injectable birth control 2Knee injuries may start with strain on the brain, not the muscles 2Protein that promotes cancer cell growth identified 2
Goat polyclonal to HA1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: TLGSCRERQPEFV from the C terminus of human HA1. Entrez GeneID: 23526 Swiss Protein ID: O78181...
... Capture high-resolution chemiluminescent and bioluminescent ... High-sensitivity camera is cooled to subzero ... dynamic range for high quality images ... light-tight cabinet provides optimum conditions for ...
Goat polyclonal to Sarcosine Oxidase ( Abpromise for all tested applications). Antigen: Microbial Sarcosine Oxidase. Entrez Gene ID: 51268 Swiss Protein ID: Q6IAJ9...
odz, odd Oz/ten-m homolog 1 [Source:RefSeq_peptide;Acc:NP_055068] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products: